In this context, Nrf2, p62, and other autophagy-related proteins have been suggested and further investigated for their potential utility in clinical protocols for assessing cancer risk, establishing prognostic scores, and determining intervention criteria for cancer patients. Here, NFE2L2 is linked to cancer.